Scarica CoroNotes - v1.9

Hai sentito parlare di CoroNotes - v1.9, o Patchwork, Jan Aushadhi Sugam (BPPI), Pacify, Inject App, MCQ Abubakr (ASU), NYP, uno dei più interessanti App della categoria Medicina.

E ovviamente lo sai, non tutti i giochi o le applicazioni sono compatibili con tutti i telefoni. Il gioco o l'applicazione a volte non è disponibile sul tuo dispositivo, dipende dalla versione del sistema. Sistema operativo Android, risoluzione dello schermo o paesi a cui Google Play consente l'accesso. Ecco perché APKPanda fornisce file APK Android da scaricare e non si attiene a queste restrizioni.>
CoroNotes - v1.9 l'ultima versione è 1.9, data di rilascio 2020-04-18 e dimensione 11.0 MB.Sviluppato da Max Planck Society, CoroNotes - v1.9 richiede almeno la versione Android . Pertanto è necessario aggiornare il telefono se necessario.

Piuttosto caricato, circa 1000 download. Puoi aggiornare le app che sono state scaricate o installate singolarmente sul tuo dispositivo Android, se lo desideri. L'aggiornamento delle tue app ti dà il permesso di accedere alle funzioni più recenti e migliora la sicurezza e la stabilità delle applicazioni.

Help to overcome the corona pandemic, protect high-risk patients and return to everyday life as quickly as possible. If you are healthy, press just one button every day. If you are ill, answer a short questionnaire every day. This will take no longer than a minute. Sometimes you can help with new trials, for example by recording your breathing sounds. The app was developed by a network of public research and health organizations and is for non-profit purposes only.

EVERY DATAPOINT HELPS SCIENCE
You think your data is not that important? Only if many people participate, important treatment and decision strategies can be derived from the data. Every single donation of data counts.

The research questions in which the data can help are roughly divided into four areas:

UNDERSTANDING CORONA
The data provide crucial insight into the complex symptomatic and asymptomatic disease progressions of COVID-19 and its dependence on health and physiological history.

RECOGNIZE HOTSPOTS
If COVID-19 is sufficiently contained, a more normal life will be possible in many places. It is then important to identify those areas where a new local outbreak is imminent. This will allow early countermeasures and better prepare hospitals.

IDENTIFY RISKS
Many infected persons feel only mild or even no symptoms at all, while others have to be given artificial respiration or die. Besides age, many other factors play a role. We want to use the data to better predict how high the risk of a severe course of the disease is for individuals, so that these people can be medically monitored at the earliest possible stage.

IMPROVE TREATMENTS
The app is intended to enable various medical studies on COVID-19 to be conducted more efficiently, more quickly and on a broader basis. This should advance the development of drugs, vaccines and treatment methods.

YOU STAY ANONYMOUS
We collect only the most necessary data - and nothing else. No motion profiles, no names, no phone numbers, no email addresses, no device information. We only store a random pseudonym and your answers to our questions, and they are about your health, not your identity. You can delete your data at any time. More in our privacy statement.

ABOUT THIS PROJECT
This project was initiated by scientists from the Tübingen AI Centre at the University of Tübingen and the Max Planck Institute for Intelligent Systems as well as medical scientists from the University Hospital Tübingen.

With this project we want to collect urgently needed data on COVID-19 as quickly and efficiently as possible and support medical and scientific studies in this field. Here, the app serves as a platform to answer as many questions as possible. To this end, continuously collected health data of as many people as possible are invaluable.

The platform as well as the collected data will be made available to trustworthy partner institutions for scientific and medical purposes regarding COVID-19.